Virtual meeting
June 22-24, 2021
All times are US EST – Color codes LIVE – SIMULIVE (pre-recorded)
Tuesday, June 22 – Day 1
9:00 – 9:10 am Welcome Remarks
BTEC Co-Presidents: Kim Johnson and Helle Broholm
9:10 – 9:30 am Presentation: International Collaboration on Cancer Reporting
Ian Cree, MBch, PhD (World Health Organization Tumor Classification, International Agency for Cancer Research, Lyon, France)
Introduction by Kim Johnson
9:30 – 9:45 am Q&A moderated by Kim Johnson and discussion
9:45 – 10:05 am Keynote lecture: Adult Brain Tumor Biomarkers 2021
Kenneth Aldape, MD (Center for Cancer Research, National Cancer Institute, Baltimore, MD, US)
Introduction by Helle Broholm
10:05 – 10:20 am Q&A moderated by Helle Broholm and discussion
10:20 – 10:30 am Coffee break
10:30 –10:50 am Keynote lecture: Childhood Brain Tumor Biomarkers 2020
Christine Haberler, MD (Institute of Neurology, Medical University of Vienna, Austria)
Introduction by Ching Lau
10:50 – 11:05 am Q&A moderated by Ching Lau and discussion
11:05 – 11:15 am American Brain Tumor Association, US Young Investigator Abstract Winner
The immuno-genetics of viral antigen response influence glioma susceptibility and survival in a subtype-specific manner
Geno Guerra, PhD University of California, San Francisco (UCSF), San Francisco, CA, USA
Introduction by Stephen Francis
11:15 – 11:20 am Q&A moderated by Stephen Francis
11:20 – 11:30 am American Brain Tumor Association, Non-US Young Investigator Abstract Winner
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: a meta-analysis of individual patient data
Christian Mirian, MD Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Introduction by Stephen Francis
11:30 – 11:35 pm Q&A moderated by Stephen Francis
11:35 – 12:15 pm Roundtable Environmental Causation and Glioma Risk Elizabeth Claus and Margaret Wrensch
Wednesday, June 23 – Day 2
8:55 – 9:00 am Welcome back to day 2 remarks
Joe Wiemels
9:00 – 9:20 am Keynote lecture: Microbiome medications and glioma risk
Judith Schwartzbaum, PhD (Division of Epidemiology, College of Public Health, Ohio State University, US)
Introduction by Friederike Erdmann
9:20 – 9:35 am Q&A moderated by Friederike Erdmann and discussion
09:35 – 09:55 am Presentation: Global Reporting of Childhood Brain Tumors Using the International Classification of Childhood Cancers (ICCC)
Fabio Girardi, MD, MPH (Cancer Survival Group, Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK)
Introduction by Friederike Erdmann
09:55 – 10:10 am Q&A moderated by Friederike Erdmann and discussion
10:10 – 10:20 am Coffee break
10:20 –11:50 pm Abstract Lectures presentations
Chair: Quinn Ostrom
10:20 -10:30 am Total DNA methylation as an epigenetic malignancy biomarker of human brain tumors
Anna-Maria Barciszewska, MD, PhD, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
10:30 -10:40 am Hormonal contraceptives and risk of meningioma: results from a Swedish register-based case-control study
Giorgio Tettamanti, PhD, Karolinska Institutet, Stockholm, Sweden
10:40 -10:50 am Parental migraine and risk of pediatric central nervous system cancers
Julia Heck, PhD, College of Health and Public Service, University of North Texas, Denton, TX, USA
10:50 -11:00 am Central Nervous System (CNS) Tumour incidence rates (2013-2017) and mortality rates (2014-2018) in Canada
Yan Yuan, PhD, School of Public Health, University of Alberta, Edmonton, Canada
11:00 -11:10 am Educational achievements among survivors of a central nervous system tumour during childhood — findings from the SALiCCS research program
Hanna Mogensen, RN Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
11:10 -11:20 am Genetic determinants of systemic inflammatory markers influence glioma risk
Linda Kachuri, MPH, PhD, University of California San Francisco (UCSF), San Francisco, CA, USA
11:20 -11:30 am A Systematic Review and Meta-analysis of Sex-Hormone Receptors in Meningioma
Danielle F. Miyagishima MD, PhD Student, Günel Lab, Department of Genetics, Yale School of Medicine, New Haven, CT, USA
11:30 -12:05 pm Q&A moderated by Quinn Ostrom and discussion
12:05 -12:15 pm Break
12:15 –1:00 pm Current Population-based Collection Practices of Molecular Markers for CNS Tumors or What’s Going On With Collection of Brain Molecular Markers in Registries?
Presentation Danish Registry
Helle Broholm, MD
Department of Pathology, Rigshospitalet, Copenhagen, Denmark
Presentation French Registry
Luc Bauchet, MD, PhD
Institute for Neurosciences, Montpellier, France
Presentation US Registry
Carol Kruchko
Central Brain Tumor Registry of the United States, Chicago, USA
Presentation Austrian Registry
Johannes Hainfellner, MD
Institute of Neurology, Medical University of Vienna, Austria
LIVE Panel Discussion
12:35 pm End of day remarks Joe Wiemels
Thursday, June 24 – Day 3
8:55 – 9:00 am Welcome back to day 3
Michael Scheurer
9:00 – 9:20 am Presentation: Biomarkers in population-based brain tumor research
Quinn Ostrom, PhD, Duke University School of Medicine, Durham, NC, USA
Introduction by Luc Bauchet
9:20 – 9:35 am Q&A moderated by Luc Bauchet and Roberta McKean-Cowdin and discussion
9:35 –11:35 pm Abstract presentations
Chair: Roberta McKean-Cowdin
09:35 -09:45 am Targeted Gene-Expression analysis during malignant transformation in primary and secondary malignant meningioma
Andrea Maier, MD, Rigshospitalet, Copenhagen, Denmark
09:45 -09:55 am Interactions of age and blood immune factors provide non-invasive predictors of glioma survival
Annette Molinaro, PhD, University of California at San Francisco (UCSF), San Francisco, CA, USA
09:55 -10:05 am Distance from reporting hospital and survival among adolescents and young adults diagnosed with CNS tumors
Kim Johnson, MPD, PhD, Washington University in St. Louis, St. Louis, MO, USA
10:05 -10:15 am Neurocutaneous syndromes, perinatal factors, and the risk of brain tumors— a cohort study among 4 million children
Christina-Evmorfia Kampitsi, Karolinska Institutet, Stockholm, Sweden
10:15 -10:30 am Q&A moderated by Roberta McKean-Cowdin and discussion
10:30– 10:40 am Coffee break
10:40 am Welcome back from break and introduction Maria Feychting
10:40 -10:50 am Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas
Gino Cioffi, MPH, Case Western Reserve University School of Medicine, Cleveland, OH, USA
10:50 -11:00 am Pre-surgery immune profile of adult glioma patients
Paige Bracci, PhD, MS, Department of Epidemiology & Biostatistics, UCSF, San Francisco, CA, USA
11:00 -11:10 am A genome-wide association analysis of childhood glioma and assessment
of the contribution of enhanced European genetic risk via admixture analysis
Shaobo Li, MD, University of Southern California, Los Angeles, CA, USA
11:10 -11:20 am Circulating cholesterol and glioma risk: results from the UK Biobank,
Nurses’ Health Study, and Health Professionals Follow-Up Study
David Cote, PhD, Brigham and Women’s Hospital, Boston, MA, USA
11:20 – 11:30 am Q&A moderated Maria Feychting and discussion
11:30– 11:50 am Presentation: Sex-specific epigenetic biomarkers in glioblastoma and primary CNS lymphoma
Adelheid Wöhrer, MD, PhD (Institute of Neurology, Medical University of Vienna, Austria)
Introduction by Maria Feychting
11:50 – 12:00 pm Q&A moderated by Maria Feychting and John Villano and discussion
12:00 – 12:20 pm Presentation: Genomic and Metabolomic biomarkers of outcomes in childhood brain tumor survivors
Michael Scheurer, PhD (Baylor College of Medicine, Houston, USA)
Introduction by John Villano
12:20 – 12:30 pm Q&A moderated by John Villano and discussion
12:30 pm Closing remarks by Michael Scheurer